Trial Profile
Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Insulin; Insulin aspart; Insulin glargine; Insulin lispro
- Indications Hyperglycaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SITA-CABGDM
- 17 Dec 2018 Status changed from recruiting to completed.
- 01 Dec 2017 Planned End Date changed from 1 Feb 2018 to 1 Mar 2019.
- 01 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.